Sintilimab Combined With Bevacizumab and TP Chemotherapy in the Treatment of High Risk Locally-advanced NPC

NCT06752382 · clinicaltrials.gov ↗

PHASE2

Phase

NOT_YET_RECRUITING

Status

58

Enrollment

OTHER

Sponsor class

Conditions

Locally Advanced Nasopharyngeal Carcinoma

Interventions

DRUG: Experimental drug

Sponsor

Zhejiang Cancer Hospital